RECENT NEWS

Roche has announced that it developed a Research Use Only (RUO) molecular PCR test, via its subsidiary TIB MOLBIOL, to detect the rare Ebola Bundibugyo virus. The test was developed within just six days.

The government has announced over £20 million of funding to improve prostate cancer research and treatment, alongside the introduction of a targeted prostate cancer screening programme.

Diagnostics firm QuidelOrtho has joined with the Allo Hope Foundation, a nonprofit dedicated to supporting families and clinicians managing maternal alloimmunisation, for a new collaboration focused on improving prenatal care through education, early testing and stronger connections between laboratory providers, clinicians and patients.

Spectral flow cytometry company Cytek Biosciences is launching its new seven-laser Cytek Borealis full spectrum flow cytometer at CYTO 2026, the industry’s premier flow cytometry conference,

Beckman Coulter Life Sciences has announced the commercial release of the Echo 650 Plus Series acoustic liquid handlers - introducing next‑generation electronics, enhanced acoustic performance, and a 54% reduction in power consumption to increase reliability, lower operating costs, and support sustainability goals in high‑throughput laboratories.

A Mount Sinai-led research team has demonstrated that autoimmunity is responsible for the often-debilitating and confounding symptoms of long COVID in a subset of people.

Developer of rapid AST (antimicrobial susceptibility testing) technology iFAST Diagnostics, has announced it has successfully closed a £5 million funding round.

The Health Research Authority (HRA) has launched a two-year plan to help support the safe and trusted use of artificial intelligence (AI) in health and social care research across the UK.

On Thursday 4 June, hospital laboratories, universities and biomedical science teams across the UK are marking Biomedical Science Day 2026 - the 10th celebration of the national awareness day dedicated to the profession behind diagnosis, treatment and disease monitoring.

Scottish Brain Sciences (SBS) has launched a new and accredited clinical laboratory service offering blood‑based biomarker and cerebrospinal fluid (CSF) testing for Alzheimer’s disease. The service increases Scotland’s capacity to provide faster, more accurate and more accessible diagnostic support for clinicians and healthcare providers across the UK.

LotusDx, a medtech company developing at-home diagnostic tests for sexually transmitted infections (STIs), has established its R&D laboratory at ONE BioHub, located on the Foresterhill Health Campus, in Aberdeen.

Leica Biosystems has announced the expansion of a collaboration to scale precision medicine and develop AI-powered diagnostics. The Danaher company is working with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 NMR in non-small cell lung cancer.

In a first for the field, all non-human primates given a new series of vaccines generated antibodies capable of fighting multiple strains of HIV.

Roche has announced the launch of its comprehensive Liver Disease Panel, a suite of certified algorithms designed to help clinicians better identify and manage chronic liver disease (CLD).

Leica Biosystems has entered into a new commercial partnership with DiaDeep, a Lyon-based company specialising in medical AI for oncology pathology, which will see DiaDeep’s AI applications available through the Aperio AI Store.

Molecular diagnostics firm Co-Diagnostics has announced that it has completed the assay development strategy for the Bundibugyo virus (BDBV) currently causing an outbreak of Ebola disease in the Democratic Republic of the Congo and Uganda.

SLAS, the Society of Laboratory Automation and Screening, welcomed 137 exhibitors and more than 1,500 registrants from more than 30 countries at its 2026 Europe Conference and Exhibition held in Vienna, Austria in May 2026.

Molecular diagnostics company Yourgene Health has launched its new Insight DPYD assay, an assay utilising genetic insights for safer chemotherapy treatments to align with updated testing guidelines.

A study led by researchers at Madrid's Centro Nacional de Investigaciones Cardiovasculares (CNIC) has identified a mitochondrial ‘checkpoint’ that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumours.

The first UKHSA One Health report tracks vector-borne diseases in England, with Lyme disease remaining the most common infection in 2025.